Jin et al. found that HK-II expression was significantly higher in phase III/IV than phase III ovarian cancer (P<0.001), and HK-II expression was significantly higher in the poorly differentiated than the highly differentiated group (P=0.008) [98]. Here, HK2 is linked to ovarian cancer.